Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40.
Department of Transplant Surgery, D. Swarovski Research Laboratory, Innsbruck University Hospital, Innsbruck, Austria. wolfgang.steurer@uibk.ac.at
W
W
Steurer
R
R
Oellinger
F
F
Perwanger
G
G
Brandacher
P
P
Obrist
G
G
Klima
R
R
Margreiter
D000069594:Abatacept; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000494:pharmacology; D018122:B7-1 Antigen / Q000187:drug effects* / Q000276:immunology; D023201:CD40 Ligand / Q000187:drug effects* / Q000276:immunology; D060908:CTLA-4 Antigen; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D013997:Time Factors; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; D018122:B7-1 Antigen; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D023201:CD40 Ligand; D000069594:Abatacept